#EKF Diagnostics – share buyback and director shareholding update
- 2025-12-29 07:40:49
EKF Diagnostics (EKF) has issued a “trading update” – it stating “reflecting strong growth in the core established business… also gives a progress update on the expansion of the Life Sciences enzyme fermentation business and on the transition of Contract Manufacturing & Laboratory Testing into non-COVID revenues”. So what of a share price response to currently 32.6p, approaching 17% lower?
Hello Share Takers. There are a few companies that are already growing because of the Covid outbreak. I’m not talking about all those hopefuls who are chasing tests and making sanitisers. But a few that are already making a solid contribution to fighting the pandemic. One such outfit is EKF Diagnostics (EKF)...
From the FCA's spreadsheet of short positions required to be disclosed to it, the following details the shorted AIM shares (by net short position %) and if this position has increased (red), reduced (green) or remained unchanged (black) since a previous analysis HERE…








